• Journal of Pharmaceutical Investigation
• /
• 제41권4호
• /
• pp.217-225
• /
• 2011

The aim of this work was to prepare porous osmotic pump tablets for controlled delivery of Aceclofenac. Aceclofenac solid dispersion was prepared to improve the solubility by using the drug - carrier (Mannitol) ratio of 1:1. The osmotic pump tablets were prepared using the solid dispersed product of Aceclofenac. The formulation contains potassium chloride as osmotic agent, cellulose acetate as semipermeable membrane, poly ethylene glycol (PEG 4000) as pore former and sodium lauryl sulphate (SLS) as solubility enhancer. The formulations were designed by the general factors such as osmotic agent and pore former. All formulations were evaluated for various physical parameters and, the in vitro release studies were conducted as per USP. The drug release kinetic studies such as zero order, first order, and Higuchi and Korsmeyer peppas were determined and compared. All the formulations gave more controlled release compared to the marketed tablet studied. Numerical optimization techniques were applied to found out the best formulation by considering the parameter of in vitro drug release kinetics and dissolution profile standards. It was concluded that the porous osmotic pump tablets (F7) composed of Aceclofenac solid dispersion/Potassium chloride/Lactose/Sodium lauryl sulphate/Magnesium Stearate (400/40/95/10/5, mg/tab) and coating composition with Cellulose acetate/ PEG 4000 (60/40 %w/w) is the most satisfactory formulation. The porous osmotic pump tablets provide prolonged, controlled, and gastrointestinal environment-independent drug release.

• 한국잡초학회지
• /
• 제10권2호
• /
• pp.122-129
• /
• 1990

Alginate와 Kaoline을 저장매체(貯藏媒體)로 사용(使用)하여 제제(製劑)한 Butachlor[N-(butoxymethyl)-2-chloro-2', 6'-diethylacetamlide] 방출조절제(放出調節劑)의 특성(特性) 및 주성분(主成分) 용출양상(溶出樣相)을 암조건(暗條件)과 일광노출(日光露出) 조건하(條件下)에서 zeolite 흡착형립제(吸着型粒劑)와 비교시험(比較試驗)하였다. Calcium alginate-Kaoline 저장체(貯藏體)에의 butachior제제율(製劑率)은 91.8%이상(以上)이었고 제품(製品)의 수율(收率)은 kaoline의 첨가량(添加量)이 증가(增加)할수록 감소(減少)하였다. 방출조절제(放出調節劑)의 수중(水中) 주성분(主成分) 용출속도(溶出速度)는 시험조건(試驗條件)에 관계(關係)없이 zeolite흡착형립체(吸着型粒劑)보다 완만(緩慢)하였고 kaoline의 함량(含量)이 증가(增加)할수록 그 속도(速度)는 현저(顯著)하게 감소(減少)하였다. 일광노출조건(日光露出條件)에서 수증기(水蒸氣)와의 공증류(共蒸溜)에 의(依)한 용출주성분(溶出主性成分)의 감소율(減少率)은 kaoline의 함량(含量)이 증가(增加)할수록 저하(低下)되는 경향(傾向)을 보였다.

• Journal of Pharmaceutical Investigation
• /
• 제36권1호
• /
• pp.39-44
• /
• 2006

Tamsulosin or a salt thereof such as its hydrochloride salt has been known to have an adrenaline ${\alpha}$ receptor blocking action for urethra and prostate areas. It has been widely used as a drug which lowers the prostate pressure and improves urinary disturbance accompanied by prostate-grand enlargement, thus for the treatment of prostatic hyperplasia. To avoid dose-dependent side effects of tamsulosin upon oral administration, the development of sustained-release delivery system is essentially required, that can maintain therapeutic drug levels for a longer period of time. The aim of this study was therefore to formulate sustained-release tamsulosin granules and assess their formulation variables. We designed entric coated sustained-release tamsulosin granules for this purpose. Nano-pores in the outer controlled release membrane were needed in order to obtain initial tamsulosin release even in an acidic environment such as gastric region. In our sustained release osmotic granule system, hydroxypropylmethylcellulose in a drug-containing layer was used as a rate controller. The drug-containing granules were coated with hydroxypropylmethylcellulose phthalate (HPMCP) and Eudragit, along with glycerol triacetate as an aqueous nano-pore former. The release of tamsulosin depended heavily on the type of Eudragit such as RS, RL, NE 30D, used in the formulation of controlled release layer. These results obtained clearly suggest that the sustained-release oral delivery system for tamsulosin could be designed with satisfying drug release profile approved by the Korean Food and Drug Administration.

• 농약과학회지
• /
• 제8권4호
• /
• pp.319-324
• /
• 2004

실리카 중공 미세구를 이용하여 방출 조절형 입제 농약을 제조합에 있어 실리카 중공 미세구 제조시 핵 제거 방법으로 열분해법을 사용하면 benfuracarb를 실리카 중공 미세구 중량의 2.67배까지 함침이 가능하였다. 이렇게 제조된 방출 조절형 입제 농약을 수중 방출 실험한 결과, 점결제로 ESO를 사용하였을 때 일정한 benfuracarb 방출 속도를 유지하여 10일부터 용액 중의 benfuracarb의 농도를 1.65 ppm 정도를 30일까지 유지되었다.

• Journal of Pharmaceutical Investigation
• /
• 제29권4호
• /
• pp.343-348
• /
• 1999

The purpose of this study is to prepare the controlled release adhesive patch containing naproxen. Pressuresensitive adhesive (PSA)-type patch was fabricated by casting of polyisobutylene (PIE.) and mineral oil in toluene. Membrane-controlled release (MCR)-type patch was prepared by the attachment of the controlled release membrane on the PSAtype patch. The membrane was mainly composed of Eudragit, polyethylene glycol(PEG) and glycerin. The drug release profile and skin permeation test with various patches were evaluated in vitro. The release of naproxen from PIE-based PSAtype patch with various loading doses fitted Higuchi's diffusion equation. However, the permeation of naproxen through hairless mouse skin from PSA-type patch followed zero-order kinetics. In MCR-type patch, thickness of controlled release membrane affected on the drug release rate highly. In the composition of membrane, the release rate was decreased as the ratio of Eudragit increased. The drug release from the MCR-type patch followed zero order kinetics. The permeation of naproxen through hairless mouse skin from MCR-type patch showed lag time for the intial release period and didn't fit the zero-order kinetics

• Archives of Pharmacal Research
• /
• 제23권4호
• /
• pp.385-390
• /
• 2000

To demonstrate the effect of formulation conditions on the controlled release of protein from poly(lactide-co-glycolide) (PLGA) microspheres for use as a parenteral drug carrier, ovalbumin (OVA) microspheres were prepared using the W/O/W multiple emulsion solvent evaporation and extraction method. Methylene chloride or ethyl acetate was applied as an organic phase and poly(vinyl alcohol) as a secondary emulsion stabilizer. Low loading efficiencies of less than 20％ were observed and the in vitro release of OVA showed a burst effect in all batches of different microspheres, followed by a gradual release over the next 6 weeks. Formulation processes affected the size and morphology, drug content, and the controlled release of OVA from PLGA microspheres.

• Journal of Pharmaceutical Investigation
• /
• 제31권1호
• /
• pp.19-25
• /
• 2001

The purpose of this study was to use a ternary polymeric matrix system for high drug loading of a highly soluble drug for controlled release delivery. The controlled drug delivery of diltiazem HCl (solubility > 50% in water at $25^{\circ}C$) with high loading dose (the final loading dose of drug was 34%) from a ternary polymeric matrix (gelatin, pectin, HPMC) was successfully accomplished. This simple monolithic system with 240 mg drug loading provided near zero-order release over a 24 hour-period by which time the system was completely dissolved. The release kinetics of diltiazem HCl tablet with high loading dose from the designed ternary polymeric system was dependent on the ratios of HPMC : pectin binary mixture. The release rate increased as pectin : HPMC ratio were increased. Swelling behavior of the ternary system and the ionic interaction of formulation components with cationic diltiazem molecule appear to control drug diffusion and the release kinetics. Comparable release profiles between commercial product and the designed system were obtained. The binding study between gelatin with diltiazem HCl showed the presence of two binding sites for drug interaction with subsequent controlled diffusion upon swelling. This designed delivery system is easy to manufacture and drug release behavior is highly reproducible and offers advantages over the existing commercial product.

• 세라미스트
• /
• 제21권3호
• /
• pp.302-308
• /
• 2018

This work reported the trends of bioceramic materials for beauty-care applications with the several represent examples - tone-up, sun-care and anti-pollution cosmetics. The development of cosmetic techniques was discussed and reviewed with various ceramic hybrid materials. Moreover, we also reported the preparation and application of functional cosmetics with silicified liposome particles as a good make-up material for controlled release with natural compounds. The homogeneous loading and highly controlled-release formulation with porous and silicified ceramic liposome ceramic materials were discussed.

• Journal of Microbiology and Biotechnology
• /
• 제9권1호
• /
• pp.50-55
• /
• 1999

To develop a new form of controlled release dosage for administering for indomethacin (IND), two formulations of IND-loaded nanoparticles were designed based on polysaccharide (guar) derivatives. Nanoparticles prepared by the dialysis method were characterized with respect to morphology, size distribution, drug content, and in vitro drug release. Morphological studies by scanning electron microscopy (SEM) indicated that guar acetate (GA) nanoparticles were spherical in shape and had a smooth surface. The particle size distributions of formulation I (40mg of GA) and formulation II (80mg of GA) were shown to be $250.78\pm185.13nm$ and $718\pm145.90nm$ in distilled water ($20$^{\circ}C$), respectively. The drug loading efficiencies of nanoparticles were approximately 26% and 31% for formulations I and II, respectively. The differential scanning calorimetry (DSC) results indicated that the IND was perfectly distributed within GA nanoparticles. We also found, from the X-ray diffractometry analysis, that a decrease in the degree of crystallinity of the drug occurred in the nanoparticles. No changes between the original IND and the released IND from GA nanoparticles were detected by FT-IR. Using guar acetate, it is possible to design nanoparticles which allow the controlled release of IND over an extended period of time.

• 한국응용곤충학회지
• /
• 제49권4호
• /
• pp.333-342
• /
• 2010

키토산 캐리어의 분자량차이에 따른 ${\alpha}$-cypermethrin 두 제형(Nano M.W. 3,000과 30,000)과 키토산 함량차이에 따른 etofenprox 두 가지 채형(Nano M.W. 30,000의 70%와 80%)의 처리후 경과일에 따른 목화진딧물과 복숭아혹진딧물의 살충율과 재체군증가율을 조사하여, 서방형 제형의 키토산 캐리어 나노제형 살충제의 실용화 가능성을 검토하였다. ${\alpha}$-cypermethrin 나노제형은 목화진딧물에 대해 처리 후 14 일이 경과했음에도 40% 정도의 살충율을 유지하고 있어 처리 후 시간이 경과했음에도 캐리어를 통한 살충제의 용출이 조절되는 것으로 확인되었다. 처리 후 4일까지는 나노타입간 차이를 보이지 않았으나, 처리 후 14 일 이후부터 키토산 분자량차이에 따른 제형간 차이를 보였는데, 키토산분자량 30,000 제형이 개체군증가율 -0.037로 3,000제형의 개체군증가율인 0.218보다 훨씬 낮아 살충효과의 지속성을 확인할 수 있었다. etofenprox는 두 종 모두의 진딧물에 대해 나노제형의 살충효과의 지속효과가 확인되지 않아 서방형 나노제형으로서 적합하지 않는 것으로 나타났다.